亚太细胞和基因治疗解冻设备市场 – 行业趋势和 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太细胞和基因治疗解冻设备市场 – 行业趋势和 2028 年预测

  • Healthcare
  • Published Report
  • Sep 2021
  • Asia-Pacific
  • 350 页面
  • 桌子數: 141
  • 图号: 55

亚太细胞和基因治疗解冻设备市场,按方式(台式和便携式)、样品(细胞疗法和基因疗法)、类型(手动解冻系统和自动解冻系统)、应用(上游处理和下游处理)、最终用户(血库和输血中心、医院和诊断实验室、研究实验室和学术机构、生物技术和制药行业、脐带血和干细胞库、基因库和其他)、分销渠道(直接招标、第三方分销商和其他)、国家(中国、韩国、日本、印度、澳大利亚、新加坡、马来西亚、印度尼西亚、泰国、菲律宾、亚太其他地区)行业趋势和预测到 2028 年。

亚太细胞和基因治疗解冻设备市场市场分析与洞察:亚太细胞和基因治疗解冻设备市场

细胞和基因治疗解冻设备市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析,在 2021 年至 2028 年的预测期内,该市场以 14.2% 的复合年增长率增长,预计到 2028 年将达到 17.7129 亿美元。心脏病、囊性纤维化和艾滋病等遗传病病例的增加需要先进的细胞和基因治疗解冻设备,从而成为细胞和基因治疗解冻设备市场增长的驱动力。

由于技术的进步,细胞和基因治疗解冻设备变得容易,因为许多主要市场参与者正在开发和推出新的解决方案来扩大其市场。此外,发达国家和发展中国家医疗保健支出的增加推动了细胞和基因治疗解冻设备市场的增长。由于慢性病发病率的增加和技术进步的提高,细胞和基因治疗解冻设备市场正在增长。

慢性病患病率的上升推动了细胞和基因治疗解冻设备市场的发展。细胞和基因治疗工程相关成本的上升降低了对细胞和基因治疗解冻设备的需求,从而限制了细胞和基因治疗解冻设备市场的增长。新技术进步的激增为细胞和基因治疗解冻设备市场带来了机遇。然而,中低收入国家缺乏可及性,这对细胞和基因治疗解冻设备市场的增长构成了挑战。

细胞和基因治疗解冻设备市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和细胞和基因治疗解冻设备市场情景,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您创建收入影响解决方案以实现您的预​​期目标。

亚太细胞和基因治疗解冻设备市场细胞和基因治疗解冻设备市场范围和市场规模

细胞和基因治疗解冻设备市场根据模式、样本、类型、应用、最终用户、分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

  • 根据样本,细胞和基因治疗解冻设备市场细分为细胞治疗和基因治疗。由于癌症患病率和发病率上升,预计 2021 年细胞治疗领域将主导细胞和基因治疗解冻设备市场。 
  • 根据类型,细胞和基因治疗解冻设备市场分为手动解冻系统和自动解冻系统。2021 年,自动解冻系统预计将主导细胞和基因治疗解冻设备市场,因为它提高了可重复性并最大限度地减少了人为错误。 
  • 根据应用,细胞和基因治疗解冻设备市场分为上游加工和下游加工。由于解冻系统的技术进步,预计 2021 年上游加工领域将主导细胞和基因治疗解冻设备市场。 
  • 根据最终用户,细胞和基因治疗解冻设备市场细分为血库和输血中心、医院和诊断实验室、研究实验室和学术机构、生物技术和制药行业、脐带血和干细胞库、基因库等。2021 年,由于中低收入国家血库和先进医疗保健提供商数量的增加,血库部门预计将在细胞和基因治疗解冻设备市场中占据主导地位。
  • 根据分销渠道,细胞和基因治疗解冻设备市场分为直接招标、第三方分销商和其他。2021 年,直接招标部分预计将主导细胞和基因治疗解冻设备市场,因为大多数医疗保健提供商都是通过直接招标采购细胞和基因治疗解冻设备的。

细胞和基因治疗解冻设备市场国家级分析

细胞和基因治疗解冻设备市场根据方式、样本、类型、应用、最终用户、分销渠道进行细分。

细胞和基因治疗解冻设备市场报告涵盖的国家包括日本、印度、澳大利亚、新加坡、马来西亚、印度尼西亚、泰国、菲律宾和亚太地区其他地区。

中国引领着亚太市场的增长,由于拥有最多的细胞和基因治疗解冻设备供应商,台式设备领域在该国占据主导地位。 

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

主要市场参与者不断增加的战略活动提高了对细胞和基因治疗解冻设备的认识,正在推动细胞和基因治疗解冻设备市场的市场增长

细胞和基因治疗解冻设备市场还为您提供每个国家特定市场增长的详细市场分析。此外,它还提供有关市场参与者战略及其地理分布的详细信息。数据适用于 2010 年至 2019 年的历史时期。

竞争格局和细胞及基因治疗解冻设备市场份额分析

细胞和基因治疗解冻设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对细胞和基因治疗解冻设备市场的关注有关。

从事细胞和基因治疗解冻设备业务的主要公司包括 Pluristem Therapeutics Inc.、Genesis BPS、Eppendorf AG、Cytiva(丹纳赫集团的子公司)、Glenmark Pharmaceutical Inc.、USA(Glenmark 的子公司)、EDGE pharma、Cook、SARSTEDT AG & Co. KG、Barkey、Boekel Scientific、LABCOLD、Sartorious AG 和 Helmer Scientific Inc. 以及其他国内公司。DBMR 分析师了解竞争优势,并为每个竞争对手分别提供竞争分析。

全球各地的公司也签订了许多合同和协议,这也加速了细胞和基因治疗解冻设备市场的发展。

例如,

  • 2020 年 11 月,Eppendorg AG 在印度推出了用于细胞解冻的 SmartBlock。Smart Block 细胞解冻是下游处理的基础。对于科学家来说,在每个细胞处理实验室中进一步使用都非常简单方便。

市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业等策略正在增强公司在细胞和基因治疗解冻设备市场的影响力,这也为组织的利润增长带来了好处。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 MARKET APPLICATION COVERAGE GRID

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES

5.1 UPSTREAM PROCESS

5.2 DOWNSTREAM PROCESS

6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT

7 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS

7.1 CANADA

7.2 THE U.S.

7.3 EUROPE

7.4 GENE THERAPY LEGISLATION IN AUSTRIA

7.5 GENE THERAPY LEGISLATION IN BULGARIA

7.6 JAPAN

7.7 ITALY

7.8 MALAYSIA

8 REGIONAL SUMMARY

9 MARKET OVERVIEW

9.1 DRIVERS

9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA

9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES

9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD

9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS

9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS

9.2 RESTRAINTS

9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING

9.2.2 RISE OF UNWANTED MUTAGENS

9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS

9.2.4 STRICT REGULATORY FRAMEWORK

9.3 OPPORTUNITIES

9.3.1 INCREASING PREVALENCE OF CANCER

9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR

9.4 CHALLENGES

9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES

9.4.2 LACK OF ACCESSIBILITY

10 IMPACT OF COVID-19 ON ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

10.1 IMPACT ON PRICE

10.2 IMPACT ON DEMAND

10.3 IMPACT ON SUPPLY CHAIN

10.4 STRATEGIC DECISION FOR MANUFACTURERS

10.5 CONCLUSION

11 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY

11.1 OVERVIEW

11.2 BENCH TOP

11.3 PORTABLE

12 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE

12.1 OVERVIEW

12.2 CELL THERAPIES

12.2.1 CAR T CELLS

12.2.2 NK CELLS

12.2.3 MSCS

12.2.4 TILS

12.2.5 OTHERS

12.3 GENE THERAPIES

12.3.1 ADENOVIRUS

12.3.2 ADENO-ASSOCIATED VIRUSES

12.3.3 LENTIVIRUSES

12.3.4 ONCOLYTIC VIRUSES

12.3.5 OTHERS

13 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE

13.1 OVERVIEW

13.2 AUTOMATIC THAWING SYSTEM

13.3 MANUAL THAWING SYSTEM

14 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION

14.1 OVERVIEW

14.2 UPSTREAM PROCESSING

14.2.1 AUTOMATIC THAWING SYSTEM

14.2.2 MANUAL THAWING SYSTEM

14.3 DOWNSTREAM PROCESSING

14.3.1 AUTOMATIC THAWING SYSTEM

14.3.2 MANUAL THAWING SYSTEM

15 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES

15.3 BLOOD BANKS AND TRANSFUSION CENTERS

15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES

15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY

15.6 CORD BLOOD AND STEM CELL BANKS

15.7 GENE BANKS

15.8 OTHERS

16 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 THIRD PARTY DISTRIBUTORS

16.4 OTHERS

17 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION

17.1 ASIA-PACIFIC

17.1.1 CHINA

17.1.2 INDIA

17.1.3 JAPAN

17.1.4 SOUTH KOREA

17.1.5 AUSTRALIA

17.1.6 SINGAPORE

17.1.7 THAILAND

17.1.8 MALAYSIA

17.1.9 INDONESIA

17.1.10 PHILIPPINES

17.1.11 REST OF ASIA PACIFIC

18 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

19 SWOT ANALYSIS

20 COMPANY PROFILE

20.1 MERCK KGAA

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 PRODUCT PORTFOLIO

20.1.4 RECENT DEVELOPMENTS

20.2 EPPENDORF AG

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 PRODUCT PORTFOLIO

20.2.4 RECENT DEVELOPMENTS

20.3 SARTORIUS AG

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 .RECENT DEVELOPMENTS

20.5 BARKEY

20.5.1 COMPANY SNAPSHOT

20.5.2 PRODUCT PORTFOLIO

20.5.3 RECENT DEVELOPMENTS

20.6 BOEKEL SCIENTIFIC

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 BIOLINE INDIA

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENTS

20.8 COOK

20.8.1 COMPANY SNAPSHOT

20.8.2 PRODUCT PORTFOLIO

20.8.3 RECENT DEVELOPMENT

20.9 GENESIS BPS

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENTS

20.1 HELMER SCIENTIFIC INC.

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENTS

20.11 LABCOLD

20.11.1 COMPANY SNAPSHOT

20.11.2 PRODUCT PORTFOLIO

20.11.3 RECENT DEVELOPMENTS

20.12 PLEURISTEM THERAPEUTICS INC.

20.12.1 COMPANY SNAPSHOT

20.12.2 REVENUE ANALYSIS

20.12.3 PRODUCT PORTFOLIO

20.12.4 RECENT DEVELOPMENTS

20.13 SARSTEDT AG & CO. KG

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENTS

21 QUESTIONNAIRE

22 RELATED REPORTS

表格列表

TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 2 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 3 ASIA PACIFIC BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 ASIA PACIFIC PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 6 ASIA PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 8 ASIA PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ASIA PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 10 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 11 ASIA PACIFIC AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 ASIA PACIFIC MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 14 ASIA PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 ASIA PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 18 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 19 ASIA PACIFIC HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA PACIFIC BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 ASIA PACIFIC RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA PACIFIC BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA PACIFIC CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA PACIFIC GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 ASIA PACIFIC OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 27 ASIA PACIFIC DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA PACIFIC OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 42 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 43 CHINA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 44 CHINA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 45 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 47 CHINA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 CHINA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 50 CHINA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 52 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 53 INDIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 54 INDIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 55 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 INDIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 58 INDIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 59 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 INDIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 62 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 63 JAPAN CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 64 JAPAN GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 65 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 JAPAN UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 JAPAN DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 70 JAPAN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 71 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 72 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 73 SOUTH KOREA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 74 SOUTH KOREA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 75 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 77 SOUTH KOREA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 SOUTH KOREA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 SOUTH KOREA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 82 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 83 AUSTRALIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 84 AUSTRALIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 85 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 87 AUSTRALIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 88 AUSTRALIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 90 AUSTRALIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 91 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 92 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 93 SINGAPORE CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 94 SINGAPORE GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 95 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 SINGAPORE UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 98 SINGAPORE DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 99 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 SINGAPORE CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 102 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 103 THAILAND CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 104 THAILAND GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 105 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 106 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 THAILAND UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 108 THAILAND DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 109 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 110 THAILAND CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 111 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 112 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 113 MALAYSIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 114 MALAYSIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 115 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 116 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 117 MALAYSIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 MALAYSIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 119 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 120 MALAYSIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 121 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 122 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 123 INDONESIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 124 INDONESIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 125 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 126 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 127 INDONESIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 128 INDONESIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 129 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 130 INDONESIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 131 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

TABLE 132 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 133 PHILIPPINES CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 134 PHILIPPINES GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)

TABLE 135 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 136 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 137 PHILIPPINES UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 138 PHILIPPINES DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 139 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 140 PHILIPPINES CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 141 REST OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)

图片列表

FIGURE 1 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION

FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028

FIGURE 15 PESTEL ANALYSIS

FIGURE 16 PORTERS FIVE FORCES MODEL

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET

FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES

FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE

FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)

FIGURE 21 ASIA PACIFIC CANCER INCIDENCE (2018)

FIGURE 22 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020

FIGURE 23 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)

FIGURE 24 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)

FIGURE 25 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 26 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020

FIGURE 27 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)

FIGURE 28 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)

FIGURE 29 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE

FIGURE 30 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020

FIGURE 31 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)

FIGURE 32 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)

FIGURE 33 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 34 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020

FIGURE 35 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 36 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 37 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 38 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020

FIGURE 39 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)

FIGURE 40 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)

FIGURE 41 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 43 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 44 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 45 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 46 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)

FIGURE 47 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)

FIGURE 48 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)

FIGURE 49 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)

FIGURE 50 ASIA-PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)

FIGURE 51 ASIA PACIFIC CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)

FIGURE 52 COMPANY SHARE ANALYSIS

FIGURE 53 COMPANY SHARE ANALYSIS

FIGURE 54 COMPANY SHARE ANALYSIS

FIGURE 55 COMPANY SHARE ANALYSIS

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.